These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24515970)
21. Modulation of the powder properties of lamotrigine by crystal forms. Kavanagh ON; Wang C; Walker GM; Sun CC Int J Pharm; 2021 Feb; 595():120274. PubMed ID: 33486026 [TBL] [Abstract][Full Text] [Related]
22. Developing Biologics Tablets: The Effects of Compression on the Structure and Stability of Bovine Serum Albumin and Lysozyme. Wei Y; Wang C; Jiang B; Sun CC; Middaugh CR Mol Pharm; 2019 Mar; 16(3):1119-1131. PubMed ID: 30698973 [TBL] [Abstract][Full Text] [Related]
23. Particle size distribution and evolution in tablet structure during and after compaction. Fichtner F; Rasmuson A; Alderborn G Int J Pharm; 2005 Mar; 292(1-2):211-25. PubMed ID: 15725568 [TBL] [Abstract][Full Text] [Related]
24. Trace polymer coated clarithromycin spherulites: Formation mechanism, improvement in pharmaceutical properties and development of high-drug-loading direct compression tablets. Zhang X; Su M; Meng W; Zhao J; Huang M; Zhang J; Qian S; Gao Y; Wei Y Int J Pharm; 2024 Apr; 654():123944. PubMed ID: 38403089 [TBL] [Abstract][Full Text] [Related]
25. A material-sparing method for assessment of powder deformation characteristics using data collected during a single compression-decompression cycle. Katz JM; Roopwani R; Buckner IS J Pharm Sci; 2013 Oct; 102(10):3687-93. PubMed ID: 23897398 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the material and tablet formation properties of modified forms of Dioscorea starches. Odeku OA; Picker-Freyer KM Drug Dev Ind Pharm; 2009 Nov; 35(11):1389-406. PubMed ID: 19832640 [TBL] [Abstract][Full Text] [Related]
27. Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design. Sun CC; Hou H; Gao P; Ma C; Medina C; Alvarez FJ J Pharm Sci; 2009 Jan; 98(1):239-47. PubMed ID: 18428197 [TBL] [Abstract][Full Text] [Related]
28. Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods. Chen H; Wang C; Kang H; Zhi B; Haynes CL; Aburub A; Sun CC Int J Pharm; 2020 Jan; 574():118914. PubMed ID: 31811924 [TBL] [Abstract][Full Text] [Related]
29. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization. Chen H; Aburub A; Sun CC J Pharm Sci; 2019 Apr; 108(4):1396-1400. PubMed ID: 30448523 [TBL] [Abstract][Full Text] [Related]
30. Analysis of the impact of material properties on tabletability by principal component analysis and partial least squares regression. Mareczek L; Riehl C; Harms M; Reichl S Eur J Pharm Sci; 2024 Sep; 200():106836. PubMed ID: 38901784 [TBL] [Abstract][Full Text] [Related]
31. Characterization of Powder- and Tablet Properties of Different Direct Compaction Grades of Mannitol Using a Kohonen Self-organizing Map and a Lasso Regression Model. Kosugi A; Leong KH; Tsuji H; Hayashi Y; Kumada S; Okada K; Onuki Y J Pharm Sci; 2020 Aug; 109(8):2585-2593. PubMed ID: 32473211 [TBL] [Abstract][Full Text] [Related]
32. Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance. Buys GM; du Plessis LH; Marais AF; Kotze AF; Hamman JH Curr Drug Deliv; 2013 Jun; 10(3):348-56. PubMed ID: 23545146 [TBL] [Abstract][Full Text] [Related]
33. A quality by design approach to investigate the effect of mannitol and dicalcium phosphate qualities on roll compaction. Souihi N; Dumarey M; Wikström H; Tajarobi P; Fransson M; Svensson O; Josefson M; Trygg J Int J Pharm; 2013 Apr; 447(1-2):47-61. PubMed ID: 23434544 [TBL] [Abstract][Full Text] [Related]
34. Transfer and scale-up of the manufacturing of orodispersible mini-tablets from a compaction simulator to an industrial rotary tablet press. Lura A; Elezaj V; Kokott M; Fischer B; Breitkreutz J Int J Pharm; 2021 Jun; 602():120636. PubMed ID: 33895296 [TBL] [Abstract][Full Text] [Related]
35. Effects of Water on Powder Flowability of Diverse Powders Assessed by Complimentary Techniques. Hirschberg C; Sun CC; Risbo J; Rantanen J J Pharm Sci; 2019 Aug; 108(8):2613-2620. PubMed ID: 30904477 [TBL] [Abstract][Full Text] [Related]
36. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153 [TBL] [Abstract][Full Text] [Related]
37. Elucidating the Impact of Material Properties on Tablet Manufacturability for Binary Paracetamol Blends. Mareczek L; Riehl C; Harms M; Reichl S Pharm Res; 2024 Jan; 41(1):185-197. PubMed ID: 37978101 [TBL] [Abstract][Full Text] [Related]
38. Review of Disintegrants and the Disintegration Phenomena. Desai PM; Liew CV; Heng PWS J Pharm Sci; 2016 Sep; 105(9):2545-2555. PubMed ID: 27506604 [TBL] [Abstract][Full Text] [Related]
39. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance. Rojas J; Buckner I; Kumar V Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909 [TBL] [Abstract][Full Text] [Related]
40. Use of a continuous twin screw granulation and drying system during formulation development and process optimization. Vercruysse J; Peeters E; Fonteyne M; Cappuyns P; Delaet U; Van Assche I; De Beer T; Remon JP; Vervaet C Eur J Pharm Biopharm; 2015 Jan; 89():239-47. PubMed ID: 25528462 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]